Literature DB >> 28380477

Utility of the Paris System in Reporting Urine Cytology.

Kiran Malviya1, Gwendolyn Fernandes, Leena Naik, Kanchan Kothari, Mona Agnihotri.   

Abstract

OBJECTIVE: To find out the utility of The Paris System (TPS) in reporting urine cytology and to compare it with the reporting system currently used in our laboratory. STUDY
DESIGN: This retrospective study was undertaken over a period of 1 year during which slides of all the urine specimens sent for cytological examination were retrieved from our laboratory filling system. They were blindly reviewed and reclassified according to TPS. Surgical follow-up was obtained from the uropathology services of our department.
RESULTS: A total of 176 cases were meticulously reviewed. The mean age of the patients was 52 years, and 71% of cases presented with hematuria. Histopathological follow-up was available in 34 cases. Reporting by TPS detected 13.0% high-grade urothelial carcinoma (HGUC) and 5.1% atypical urothelial cells versus 7.3 and 11.9% by the current reporting system, respectively. The sensitivity and diagnostic accuracy for detecting HGUC of TPS were higher than those of our reporting system.
CONCLUSION: TPS has increased the rate of detection of HGUC and reduced the rate of reporting "atypical" urothelial cells. TPS has also standardized the diagnostic criteria, thereby bringing uniformity and reproducibility into the system of reporting for urine cytology.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Atypical urothelial cells; Paris System; Urine cytology; Urothelial carcinoma

Mesh:

Year:  2017        PMID: 28380477     DOI: 10.1159/000464270

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  6 in total

1.  Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study.

Authors:  Vittorio Fasulo; Marco Paciotti; Massimo Lazzeri; Roberto Contieri; Paolo Casale; Alberto Saita; Giovanni Lughezzani; Pietro Diana; Nicola Frego; Pier Paolo Avolio; Piergiuseppe Colombo; Grazia Maria Elefante; Giorgio Guazzoni; Nicolò Maria Buffi; Michael Bates; Rodolfo Hurle
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

2.  A Quest for Accuracy: Evaluation of The Paris System in Diagnosis of Urothelial Carcinomas.

Authors:  Sharada Rai; Bhagat S Lali; Chaithra G Venkataramana; Cheryl S Philipose; Ranjitha Rao; Gg Laxman Prabhu
Journal:  J Cytol       Date:  2019 Jul-Sep       Impact factor: 1.000

3.  Impact of the Paris system for reporting urine cytopathology on predictive values of the equivocal diagnostic categories and interobserver agreement.

Authors:  Rania Bakkar; James Mirocha; Xuemo Fan; David P Frishberg; Mariza de Peralta-Venturina; Jing Zhai; Shikha Bose
Journal:  Cytojournal       Date:  2019-10-22       Impact factor: 2.091

4.  Analytical and Post Analytical Phase of an ISO 15189:2012 Certified Cytopathology Laboratory-A Five Year Institutional Experience.

Authors:  Smita Chandra; Anuradha Kusum; Dushyant Singh Gaur; Harish Chandra
Journal:  J Cytol       Date:  2022-02-03       Impact factor: 1.000

Review 5.  The Paris System for Reporting Urinary Cytology: A Meta-Analysis.

Authors:  Ilias P Nikas; Svenja Seide; Tanja Proctor; Zoi Kleinaki; Maria Kleinaki; Jordan P Reynolds
Journal:  J Pers Med       Date:  2022-01-27

6.  Diagnostic Agreement for High-Grade Urothelial Cell Carcinoma in Atypical Urine Cytology: A Nationwide Survey Reveals a Tendency for Overestimation in Specimens with an N/C Ratio Approaching 0.5.

Authors:  Yeh-Han Wang; Jen-Fan Hang; Chien-Hui Wen; Kuan-Cho Liao; Wen-Ying Lee; Chiung-Ru Lai
Journal:  Cancers (Basel)       Date:  2020-01-22       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.